Susquehanna Fundamental Investments LLC Invests $616,000 in Oscar Health, Inc. (NYSE:OSCR)

Market Beat
2025.05.05 08:32
portai
I'm PortAI, I can summarize articles.

Susquehanna Fundamental Investments LLC has invested $616,000 in Oscar Health, Inc. (NYSE:OSCR) by acquiring 45,860 shares in the fourth quarter. Other investors, including Tower Research Capital and KBC Group, have also increased their stakes. Currently, 75.70% of the stock is held by institutional investors. Analysts have mixed ratings on the stock, with a consensus rating of "Hold" and a target price of $20.21. Oscar Health's shares opened at $13.19, with a market cap of $3.30 billion and a recent EPS of ($0.62).

Susquehanna Fundamental Investments LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 45,860 shares of the company's stock, valued at approximately $616,000.

Other large investors have also recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its holdings in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after buying an additional 4,185 shares in the last quarter. KBC Group NV raised its holdings in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new position in Oscar Health during the fourth quarter worth approximately $100,000. Alberta Investment Management Corp acquired a new stake in Oscar Health in the fourth quarter valued at approximately $138,000. Finally, Virtu Financial LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at approximately $140,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $20.21.

View Our Latest Stock Analysis on OSCR

Oscar Health Price Performance

Shares of NYSE OSCR opened at $13.19 on Friday. The firm has a 50-day simple moving average of $13.30 and a 200-day simple moving average of $14.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of -659.17 and a beta of 1.75. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Recommended Stories

  • Five stocks we like better than Oscar Health
  • How to Use the MarketBeat Excel Dividend Calculator
  • Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2
  • 3 Defense Stocks Set to Benefit From Increased Military Spending
  • Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious
  • Are Penny Stocks a Good Fit for Your Portfolio?
  • Palantir Earnings: 1 Bullish Signal and 1 Area of Concern

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.